Mastering the complexities of active pharmaceutical ingredient (API) commercial production is crucial for ensuring the consistent quality, efficacy, and safety of pharmaceutical products. It is also a strategic imperative for successfully launching and maintaining drug products in the market, as it directly impacts the drug's reliability and consumer trust.

A CDMO partner's role in this journey is pivotal, offering guidance and solutions that pave the way for commercial success. This webinar will describe Thermo Fisher Scientific’s holistic approach to API commercial production, which encompasses scalability, sustainability, cost optimization, and manufacturing flexibility.

From leveraging advanced technologies and processes for scalable production to adopting sustainable practices and ensuring regulatory compliance, our experts will explore strategies for significantly enhancing the commercial production process, whether producing an orphan drug or a mass market product. Using real-life scenarios, they will demonstrate the importance of working with a CDMO partner that has the resources, expertise, and flexibility to advance an API from early process development to commercial readiness.

Participants will learn about:

• The criteria to look for in a potential CDMO partner
• Approaches for responsible and sustainable raw material sourcing
• Strategies for innovative optimization of manufacturing processes and costs
• Benefits of leveraging a network of sites for scalable commercialization
• Methods for ensuring a sustainable supply throughout the product lifecycle

Who should attend

This webinar is a must-attend for professionals in the pharmaceutical industry seeking to enhance their API commercial production strategy. Participants will leave with actionable knowledge on selecting the right CDMO partner, ensuring their projects, regardless of scale, are set up for success in the competitive pharmaceutical market.